الفهرس 
Non-Alcoholic Fatty Liver DiseaseOnly 14 pages are availabe for public view
 |  | from | 151 |  |  |
| | | from | 151 | | |
Abstract
Background; Omentin‐ 1 and chemerin have been identified as interesting novel adipokines that may modulate insulin action. Also, they have been suggested to be linked to obesity‐ induced insulin resistance, Aim and objectives; To evaluate the assessment of omentin-1 as an adipokine in obese male and females with and without fatty liver disease, Subjects and methods; This is a comparative case control study, was carried out at outpatients clinics of internal medicine department of Ain Shams University,on 40 patients divided into two groups: group (A): 20 patient with fatty liver 10 of them obese and 10non obese group (B):20 not have fatty live 10obese and 10 non obese, from November 2019 till May 2020, Results: there was high statistically significant difference between the four studied subgroups as regard Triglycerides and statistically significant difference as regard Cholesterol and LDL.C, Conclusion; Our results suggest that serum omentin levels are raised in patients with NAFLD regardless of potential confounders and represent an independent predictor of hepatocyte ballooning. Also, decreased omentin levels have a close association with metabolic syndrome in women with morbid obesity